108 related articles for article (PubMed ID: 28796361)
1. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
McIver B; Grebe SKG; Wang L; Hay ID; Yokomizo ; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-757. PubMed ID: 28796361
[TBL] [Abstract][Full Text] [Related]
2. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
[TBL] [Abstract][Full Text] [Related]
3. Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours.
Gayther SA; Barski P; Batley SJ; Li L; de Foy KA; Cohen SN; Ponder BA; Caldas C
Oncogene; 1997 Oct; 15(17):2119-26. PubMed ID: 9366528
[TBL] [Abstract][Full Text] [Related]
4. FHIT gene abnormalities in both benign and malignant thyroid tumours.
Zou M; Shi Y; Farid NR; al-Sedairy ST; Paterson MC
Eur J Cancer; 1999 Mar; 35(3):467-72. PubMed ID: 10448301
[TBL] [Abstract][Full Text] [Related]
5. Aberrant transcripts of FHIT, TSG101 and PTEN/MMAC1 genes in normal peripheral mononuclear cells.
Wang NM; Chang JG; Liu TC; Lin SF; Peng CT; Tsai FJ; Tsai CH
Int J Oncol; 2000 Jan; 16(1):75-80. PubMed ID: 10601551
[TBL] [Abstract][Full Text] [Related]
6. Expression of abnormal transcripts of the FHIT (fragile histidine triad) gene in ovarian carcinoma.
Mandai M; Konishi I; Kuroda H; Nanbu K; Matsushita K; Yura Y; Hamid AA; Mori T
Eur J Cancer; 1998 Apr; 34(5):745-9. PubMed ID: 9713284
[TBL] [Abstract][Full Text] [Related]
7. Aberrant splicing of the TSG101 tumor suppressor gene in human breast and ovarian cancers.
Carney ME; Maxwell GL; Lancaster JM; Gumbs C; Marks J; Berchuck A; Futreal PA
J Soc Gynecol Investig; 1998; 5(5):281-5. PubMed ID: 9773405
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression and deletion of FHIT gene in leukemias.
Wang L; Dong LJ; Tian F; Liu GX; Li CH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Apr; 11(2):153-60. PubMed ID: 12744737
[TBL] [Abstract][Full Text] [Related]
9. [Sequence analyses of aberrant FHIT transcripts in gastric cancer cell lines].
Lee SH; Kim HS
Korean J Gastroenterol; 2003 Dec; 42(6):476-83. PubMed ID: 14695704
[TBL] [Abstract][Full Text] [Related]
10. High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer.
Huiping C; Kristjansdottir S; Bergthorsson JT; Jonasson JG; Magnusson J; Egilsson V; Ingvarsson S
Eur J Cancer; 2002 Mar; 38(5):728-35. PubMed ID: 11916557
[TBL] [Abstract][Full Text] [Related]
11. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma.
Segawa T; Sasagawa T; Yamazaki H; Sakaike J; Ishikawa H; Inoue M
Cancer; 1999 May; 85(9):2001-10. PubMed ID: 10223242
[TBL] [Abstract][Full Text] [Related]
12. Impaired FHIT expression characterizes serous ovarian carcinoma.
Ozaki K; Enomoto T; Yoshino K; Fujita M; Buzard GS; Kawano K; Yamasaki M; Murata Y
Br J Cancer; 2001 Jul; 85(2):247-54. PubMed ID: 11461085
[TBL] [Abstract][Full Text] [Related]
13. Aberrant splicing of FHIT transcripts in human gastric cancer cell lines.
Lee SH; Kim HY; Kim TJ; Park HK; Kim WH; Woo KM; Cho MH
Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):39-49. PubMed ID: 15080495
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas.
Lee SH; Kim WH; Kim HK; Woo KM; Nam HS; Kim HS; Kim JG; Cho MH
Biochem Biophys Res Commun; 2001 Jun; 284(3):850-5. PubMed ID: 11396980
[TBL] [Abstract][Full Text] [Related]
15. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
Greenspan DL; Connolly DC; Wu R; Lei RY; Vogelstein JT; Kim YT; Mok JE; Muñoz N; Bosch FX; Shah K; Cho KR
Cancer Res; 1997 Nov; 57(21):4692-8. PubMed ID: 9354423
[TBL] [Abstract][Full Text] [Related]
16. FHIT gene alterations in esophageal cancer and ulcerative colitis (UC).
Zou TT; Lei J; Shi YQ; Yin J; Wang S; Souza RF; Kong D; Shimada Y; Smolinski KN; Greenwald BD; Abraham JM; Harpaz N; Meltzer SJ
Oncogene; 1997 Jul; 15(1):101-5. PubMed ID: 9233782
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the FHIT gene and its product in squamous cell carcinomas of the head and neck.
Kisielewski AE; Xiao GH; Liu SC; Klein-Szanto AJ; Novara M; Sina J; Bleicher K; Yeung RS; Goodrow TL
Oncogene; 1998 Jul; 17(1):83-91. PubMed ID: 9671317
[TBL] [Abstract][Full Text] [Related]
18. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
[TBL] [Abstract][Full Text] [Related]
19. Aberrant TSG101 transcripts in acute myeloid leukaemia.
Lin PM; Liu TC; Chang JG; Chen TP; Lin SF
Br J Haematol; 1998 Aug; 102(3):753-8. PubMed ID: 9722303
[TBL] [Abstract][Full Text] [Related]
20. Aberrant FHIT transcripts in human colorectal cancers.
Lee SH; Lee SH
Res Commun Mol Pathol Pharmacol; 2005; 117-118():153-65. PubMed ID: 18426086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
